I'm not sure that's entirely correct. The first timeline we saw for azer-cel (at the time of purchase) targeted Q3 2024 for a Phase 1b readout, so 2H 2024 is still accurate.
The more recent JPM slides show 2 updates for azer-cel across 2024 one in Q2 (enrolment) and one in Q3 (readout). So I don't think the timeline there has slipped at all?
And as far as no immediate updates, I would think, given Vaxinia's preliminary enrolment update of April 24 '24, that the next data cut would not be too far off. To speculate, I *think* they would want to see all Cohort 5 patients cross the 42 day mark first. So as of April 24, there are still 7 Cohort 5 patients that have not yet had their 42 day scan.
Perhaps June for the next cut? Or maybe we're lucky and will see something mid May.
GLTAH.
- Forums
- ASX - By Stock
- IMU
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-39
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $394.1M |
Open | High | Low | Value | Volume |
5.3¢ | 5.5¢ | 5.2¢ | $1.975M | 36.88M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 4400559 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 1340583 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 4281692 | 0.053 |
36 | 4949951 | 0.052 |
40 | 4868523 | 0.051 |
87 | 7824193 | 0.050 |
12 | 2689732 | 0.049 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 1340583 | 5 |
0.055 | 2547751 | 8 |
0.056 | 1870379 | 13 |
0.057 | 1083442 | 9 |
0.058 | 369738 | 3 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |